| Dr David Wendell Martin, MD | |
|
178 Douglas Parkway, Prestonsburg, KY 41501-6970 | |
| (606) 639-3135 | |
| (606) 639-3136 |
| Full Name | Dr David Wendell Martin |
|---|---|
| Gender | Male |
| Speciality | Family Practice |
| Experience | 29 Years |
| Location | 178 Douglas Parkway, Prestonsburg, Kentucky |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1619195864 | NPI | - | NPPES |
| 000000523945 | Other | KY | ANTHEM |
| 1529561 | Other | KY | UMWA |
| 164138200 | Other | KY | FEDERAL BLACK LUNG |
| 64343593 | Medicaid | KY | |
| 611330253 | Other | KY | COMMERCIAL INS |
| 000000042976 | Other | KY | BLUE CROSS BLUE SHIELD |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | 34359 (Kentucky) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Pikeville Medical Center | Pikeville, KY | Hospital |
| Landmark Of Elkhorn City Rehabilitation And Nursin | Elkhorn city, KY | Nursing home |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Big Sandy Health Care, Inc | 1951211218 | 47 |
News Archive
From targeted cancer chemotherapy to the guarantee of successful organ transplants, the 21st century may prove to be the age of big ideas in medicine. The drugs themselves, though, will be miniscule. Experts in chemistry, applied physics, materials science, and pharmaceutical science are gathering this week for the BASF Advanced Research Initiative at Harvard University's symposium on pharmaceutical nanoformulations.
Governor Edward G. Rendell has signed into law Senate Bill 240, a measure to update and enhance Pennsylvania's existing Emergency Medical Services Act. The law was first enacted in 1985.
MicroBiome Therapeutics LLC, a biotechnology company developing pharmaceutical and medical food products that shift the human microbiome in specific ways for improved health, today reported publication of a case report suggesting a potentially important new application for its lead product, NM504. NM504 is in clinical development to promote healthy blood glucose levels and metabolic fitness in prediabetic and diabetic populations.
Politico: "Senate Majority Leader Harry Reid's plan to pass the Senate health care reform bill by Christmas looked increasingly in doubt Wednesday, as Republicans launched an offensive to stall the legislation and Democrats had yet to strike a 60-vote compromise.
Embera NeuroTherapeutics, Inc., a specialty pharmaceutical company developing novel treatments for drug dependence, smoking cessation and obesity, announced today that the company has retained Exponential Pharma Ventures LLC to assist in establishing a clinical development partnership for its cocaine dependence program with a fully integrated pharmaceutical company.
› Verified 5 days ago
| Entity Name | Pikeville Medical Center Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1528195864 PECOS PAC ID: 6709790157 Enrollment ID: O20040304001281 |
News Archive
From targeted cancer chemotherapy to the guarantee of successful organ transplants, the 21st century may prove to be the age of big ideas in medicine. The drugs themselves, though, will be miniscule. Experts in chemistry, applied physics, materials science, and pharmaceutical science are gathering this week for the BASF Advanced Research Initiative at Harvard University's symposium on pharmaceutical nanoformulations.
Governor Edward G. Rendell has signed into law Senate Bill 240, a measure to update and enhance Pennsylvania's existing Emergency Medical Services Act. The law was first enacted in 1985.
MicroBiome Therapeutics LLC, a biotechnology company developing pharmaceutical and medical food products that shift the human microbiome in specific ways for improved health, today reported publication of a case report suggesting a potentially important new application for its lead product, NM504. NM504 is in clinical development to promote healthy blood glucose levels and metabolic fitness in prediabetic and diabetic populations.
Politico: "Senate Majority Leader Harry Reid's plan to pass the Senate health care reform bill by Christmas looked increasingly in doubt Wednesday, as Republicans launched an offensive to stall the legislation and Democrats had yet to strike a 60-vote compromise.
Embera NeuroTherapeutics, Inc., a specialty pharmaceutical company developing novel treatments for drug dependence, smoking cessation and obesity, announced today that the company has retained Exponential Pharma Ventures LLC to assist in establishing a clinical development partnership for its cocaine dependence program with a fully integrated pharmaceutical company.
› Verified 5 days ago
| Entity Name | Big Sandy Health Care, Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1104055805 PECOS PAC ID: 1951211218 Enrollment ID: O20040510000841 |
News Archive
From targeted cancer chemotherapy to the guarantee of successful organ transplants, the 21st century may prove to be the age of big ideas in medicine. The drugs themselves, though, will be miniscule. Experts in chemistry, applied physics, materials science, and pharmaceutical science are gathering this week for the BASF Advanced Research Initiative at Harvard University's symposium on pharmaceutical nanoformulations.
Governor Edward G. Rendell has signed into law Senate Bill 240, a measure to update and enhance Pennsylvania's existing Emergency Medical Services Act. The law was first enacted in 1985.
MicroBiome Therapeutics LLC, a biotechnology company developing pharmaceutical and medical food products that shift the human microbiome in specific ways for improved health, today reported publication of a case report suggesting a potentially important new application for its lead product, NM504. NM504 is in clinical development to promote healthy blood glucose levels and metabolic fitness in prediabetic and diabetic populations.
Politico: "Senate Majority Leader Harry Reid's plan to pass the Senate health care reform bill by Christmas looked increasingly in doubt Wednesday, as Republicans launched an offensive to stall the legislation and Democrats had yet to strike a 60-vote compromise.
Embera NeuroTherapeutics, Inc., a specialty pharmaceutical company developing novel treatments for drug dependence, smoking cessation and obesity, announced today that the company has retained Exponential Pharma Ventures LLC to assist in establishing a clinical development partnership for its cocaine dependence program with a fully integrated pharmaceutical company.
› Verified 5 days ago
| Entity Name | Big Sandy Health Care, Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1922594506 PECOS PAC ID: 1951211218 Enrollment ID: O20181008002523 |
News Archive
From targeted cancer chemotherapy to the guarantee of successful organ transplants, the 21st century may prove to be the age of big ideas in medicine. The drugs themselves, though, will be miniscule. Experts in chemistry, applied physics, materials science, and pharmaceutical science are gathering this week for the BASF Advanced Research Initiative at Harvard University's symposium on pharmaceutical nanoformulations.
Governor Edward G. Rendell has signed into law Senate Bill 240, a measure to update and enhance Pennsylvania's existing Emergency Medical Services Act. The law was first enacted in 1985.
MicroBiome Therapeutics LLC, a biotechnology company developing pharmaceutical and medical food products that shift the human microbiome in specific ways for improved health, today reported publication of a case report suggesting a potentially important new application for its lead product, NM504. NM504 is in clinical development to promote healthy blood glucose levels and metabolic fitness in prediabetic and diabetic populations.
Politico: "Senate Majority Leader Harry Reid's plan to pass the Senate health care reform bill by Christmas looked increasingly in doubt Wednesday, as Republicans launched an offensive to stall the legislation and Democrats had yet to strike a 60-vote compromise.
Embera NeuroTherapeutics, Inc., a specialty pharmaceutical company developing novel treatments for drug dependence, smoking cessation and obesity, announced today that the company has retained Exponential Pharma Ventures LLC to assist in establishing a clinical development partnership for its cocaine dependence program with a fully integrated pharmaceutical company.
› Verified 5 days ago
| Entity Name | Big Sandy Health Care, Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1972173136 PECOS PAC ID: 1951211218 Enrollment ID: O20210901001642 |
News Archive
From targeted cancer chemotherapy to the guarantee of successful organ transplants, the 21st century may prove to be the age of big ideas in medicine. The drugs themselves, though, will be miniscule. Experts in chemistry, applied physics, materials science, and pharmaceutical science are gathering this week for the BASF Advanced Research Initiative at Harvard University's symposium on pharmaceutical nanoformulations.
Governor Edward G. Rendell has signed into law Senate Bill 240, a measure to update and enhance Pennsylvania's existing Emergency Medical Services Act. The law was first enacted in 1985.
MicroBiome Therapeutics LLC, a biotechnology company developing pharmaceutical and medical food products that shift the human microbiome in specific ways for improved health, today reported publication of a case report suggesting a potentially important new application for its lead product, NM504. NM504 is in clinical development to promote healthy blood glucose levels and metabolic fitness in prediabetic and diabetic populations.
Politico: "Senate Majority Leader Harry Reid's plan to pass the Senate health care reform bill by Christmas looked increasingly in doubt Wednesday, as Republicans launched an offensive to stall the legislation and Democrats had yet to strike a 60-vote compromise.
Embera NeuroTherapeutics, Inc., a specialty pharmaceutical company developing novel treatments for drug dependence, smoking cessation and obesity, announced today that the company has retained Exponential Pharma Ventures LLC to assist in establishing a clinical development partnership for its cocaine dependence program with a fully integrated pharmaceutical company.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr David Wendell Martin, MD 1709 Ky Route 321, Suite 3, Prestonsburg, KY 41653 Ph: (606) 886-8546 | Dr David Wendell Martin, MD 178 Douglas Parkway, Prestonsburg, KY 41501-6970 Ph: (606) 639-3135 |
News Archive
From targeted cancer chemotherapy to the guarantee of successful organ transplants, the 21st century may prove to be the age of big ideas in medicine. The drugs themselves, though, will be miniscule. Experts in chemistry, applied physics, materials science, and pharmaceutical science are gathering this week for the BASF Advanced Research Initiative at Harvard University's symposium on pharmaceutical nanoformulations.
Governor Edward G. Rendell has signed into law Senate Bill 240, a measure to update and enhance Pennsylvania's existing Emergency Medical Services Act. The law was first enacted in 1985.
MicroBiome Therapeutics LLC, a biotechnology company developing pharmaceutical and medical food products that shift the human microbiome in specific ways for improved health, today reported publication of a case report suggesting a potentially important new application for its lead product, NM504. NM504 is in clinical development to promote healthy blood glucose levels and metabolic fitness in prediabetic and diabetic populations.
Politico: "Senate Majority Leader Harry Reid's plan to pass the Senate health care reform bill by Christmas looked increasingly in doubt Wednesday, as Republicans launched an offensive to stall the legislation and Democrats had yet to strike a 60-vote compromise.
Embera NeuroTherapeutics, Inc., a specialty pharmaceutical company developing novel treatments for drug dependence, smoking cessation and obesity, announced today that the company has retained Exponential Pharma Ventures LLC to assist in establishing a clinical development partnership for its cocaine dependence program with a fully integrated pharmaceutical company.
› Verified 5 days ago
Mohammed Akhlack Hossain Mazumder, M.D. Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 92 Pickett Ln, Prestonsburg, KY 41653 Phone: 606-874-0112 Fax: 606-874-0115 | |
Dr. Drema K Hunt, MD Family Medicine Medicare: Medicare Enrolled Practice Location: 5230 Ky Route 321 Ste 8, Prestonsburg, KY 41653 Phone: 606-886-1970 Fax: 606-886-3668 | |
Dr. Jessica Lee Branham, D.O. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 104 S Front Ave, Prestonsburg, KY 41653 Phone: 606-886-8572 | |
Matthew Kyle Turner, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 400 University Dr, Prestonsburg, KY 41653 Phone: 606-886-3831 Fax: 606-886-9908 | |
Dr. Seema Sachdeva, M.D. Family Medicine Medicare: Medicare Enrolled Practice Location: 104 S Front Ave, Prestonsburg, KY 41653 Phone: 606-886-8572 Fax: 606-886-4433 | |
Christopher M Bailey, DO Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 400 University Dr, Suite 101-a, Prestonsburg, KY 41653 Phone: 606-886-3831 Fax: 606-886-3440 | |
Dr. Denielle Holt, D.O. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 5000 Ky Route 321, Prestonsburg, KY 41653 Phone: 606-439-1559 |